Similar articles

• The effects of two antidepressants, imipramine and viloxazine, upon driving performance.

  Clayton AB, Harvey PG, Betts TA. Clayton AB, et al. Psychopharmacology (Berl). 1977 Nov 24;55(1):9-12. doi: 10.1007/BF00432810. Psychopharmacology (Berl). 1977. PMID: 414266 Clinical Trial.
• [Experiments of the viloxazine-noradrenaline interaction on the atrium and the isolated ductus defens of the rat. Comparison with imipramine].

  García Morillas M, Puche E, Mundo A, Arias A. García Morillas M, et al. Arch Farmacol Toxicol. 1980 Apr;6(1):83-8. Arch Farmacol Toxicol. 1980. PMID: 7387207 Spanish. No abstract available.
• Viloxazine: a review of the literature.

  Ban TA, McEvoy JP, Wilson WH. Ban TA, et al. Int Pharmacopsychiatry. 1980;15(2):118-23. doi: 10.1159/000468422. Int Pharmacopsychiatry. 1980. PMID: 7002831 Review.
• Pharmacological comparison of the potential antidepressant UP 614-04 with viloxazine and imipramine; behavioral studies.

  Meignen J, Grognet A, Deniard MJ, Dalphrase F, Roux E, DeFeudis FV. Meignen J, et al. Gen Pharmacol. 1982;13(5):381-91. doi: 10.1016/0306-3623(82)90103-3. Gen Pharmacol. 1982. PMID: 6890919
• Viloxazine and neurotransmitter function.

  Greenwood DT. Greenwood DT. Adv Biochem Psychopharmacol. 1982;31:287-300. Adv Biochem Psychopharmacol. 1982. PMID: 6282059 Review. No abstract available.